Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM

European Journal of Heart Failure · Published 2026-07-31 · DOI 10.1093/ejhf/xuag244

Free full text

Authors (26)

Shepard D Weiner, Lusha W Liang, Ahmad Masri, Theodore P Abraham, Roberto Barriales-Villa, Robert M Cooper, Perry M Elliott, Alejandro de Feria, Martin S Maron, Artur Oreziak, Sara Saberi, Scott D Solomon, John A Spertus, Albree Tower-Rader, Michael Butzner, Justin Godown, Stephen B Heitner, Daniel L Jacoby, Stuart Kupfer, Xueli Liu, Fady I Malik, Chiara Melloni, Tyrell J Simkins, Jenny Wei, Michael E Nassif, Anjali T Owens

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Weiner, S., Liang, L., Masri, A., et al. (2026). Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag244

Related articles